Piramal Pharma Limited (PPLPHARMA.BO)
INR 260.3
(-1.68%)
INR 260.3
(-1.68%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 81.71 Billion INR | 15.91% |
| 2022 | 70.49 Billion INR | 8.38% |
| 2021 | 65.03 Billion INR | 121.31% |
| 2020 | 29.38 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 22.41 Billion INR | 14.89% |
| 2024 Q1 | 19.51 Billion INR | -23.56% |
| 2023 Q1 | 17.48 Billion INR | -17.95% |
| 2023 FY | 81.71 Billion INR | 15.91% |
| 2023 Q4 | 25.52 Billion INR | 30.32% |
| 2023 Q3 | 19.58 Billion INR | 2.47% |
| 2023 Q2 | 19.11 Billion INR | 9.29% |
| 2022 Q2 | 17.2 Billion INR | 16.06% |
| 2022 Q1 | 14.81 Billion INR | 211.23% |
| 2022 FY | 70.49 Billion INR | 8.38% |
| 2022 Q4 | 21.31 Billion INR | 24.2% |
| 2022 Q3 | 17.15 Billion INR | -0.23% |
| 2021 Q2 | 15.77 Billion INR | 0.0% |
| 2021 FY | 65.03 Billion INR | 121.31% |
| 2021 Q4 | -13.32 Billion INR | -186.57% |
| 2021 Q3 | 15.39 Billion INR | -2.43% |
| 2020 FY | 29.38 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Ajanta Pharma Limited | 42.08 Billion INR | -94.149% |
| Amrutanjan Health Care Limited | 4.21 Billion INR | -1839.831% |
| Sigachi Industries Limited | 3.98 Billion INR | -1948.135% |
| Bal Pharma Limited | 3.39 Billion INR | -2308.811% |
| Ind-Swift Laboratories Limited | 12.8 Billion INR | -537.923% |
| Medico Remedies Limited | 1.44 Billion INR | -5538.366% |
| Lasa Supergenerics Limited | 1.04 Billion INR | -7731.658% |
| Venus Remedies Limited | 5.91 Billion INR | -1281.548% |
| Sun Pharma Advanced Research Company Limited | 755.45 Million INR | -10716.239% |
| Alpa Laboratories Limited | 1.08 Billion INR | -7414.47% |
| Nectar Lifesciences Limited | 16.84 Billion INR | -385.198% |
| Shilpa Medicare Limited | 11.51 Billion INR | -609.547% |
| Aarti Drugs Limited | 25.28 Billion INR | -223.153% |
| Lupin Limited | 200.1 Billion INR | 59.166% |
| Aurobindo Pharma Limited | 287.04 Billion INR | 71.534% |
| Zydus Lifesciences Limited | 190.21 Billion INR | 57.043% |
| Windlas Biotech Limited | 6.3 Billion INR | -1195.044% |
| Suven Life Sciences Limited | 116.92 Million INR | -69781.381% |
| Eris Lifesciences Limited | 20.09 Billion INR | -306.699% |
| Valiant Laboratories Limited | 1.82 Billion INR | -4388.238% |
| J. B. Chemicals & Pharmaceuticals Limited | 34.84 Billion INR | -134.521% |
| Solara Active Pharma Sciences Limited | 12.38 Billion INR | -559.821% |
| Ipca Laboratories Limited | 76.22 Billion INR | -7.199% |
| Bliss GVS Pharma Limited | 7.7 Billion INR | -960.852% |
| Achyut Healthcare Limited | 61.36 Million INR | -133048.006% |
| Sun Pharmaceutical Industries Limited | 484.96 Billion INR | 83.151% |
| Bajaj HealthCare Limited | 4.73 Billion INR | -1625.993% |
| RPG Life Sciences Limited | 5.82 Billion INR | -1303.859% |
| Mankind Pharma Limited | 103.34 Billion INR | 20.935% |
| Laurus Labs Limited | 50.01 Billion INR | -63.364% |
| Syncom Formulations (India) Limited | 2.59 Billion INR | -3051.919% |
| Torrent Pharmaceuticals Limited | 106.05 Billion INR | 22.953% |
| Alembic Pharmaceuticals Limited | 61.12 Billion INR | -33.688% |
| Glenmark Pharmaceuticals Limited | 118.13 Billion INR | 30.83% |
| Unichem Laboratories Limited | 16.57 Billion INR | -393.006% |
| Sequent Scientific Limited | 13.69 Billion INR | -496.552% |
| Novartis India Limited | 3.35 Billion INR | -2338.643% |
| Wanbury Limited | 5.75 Billion INR | -1319.467% |
| Suven Pharmaceuticals Limited | 10.51 Billion INR | -677.204% |
| Wockhardt Limited | 27.89 Billion INR | -192.978% |
| Themis Medicare Limited | 3.81 Billion INR | -2040.387% |
| Jagsonpal Pharmaceuticals Limited | 2.08 Billion INR | -3815.228% |
| Jubilant Pharmova Limited | 67.02 Billion INR | -21.905% |
| Glenmark Life Sciences Limited | 22.83 Billion INR | -257.88% |
| Dr. Reddy's Laboratories Limited | 279.16 Billion INR | 70.73% |
| Divi's Laboratories Limited | 78.45 Billion INR | -4.158% |
| NATCO Pharma Limited | 40.02 Billion INR | -104.177% |
| Gufic Biosciences Limited | 8.06 Billion INR | -912.955% |
| IOL Chemicals and Pharmaceuticals Limited | 21.18 Billion INR | -285.621% |
| Ind-Swift Limited | 5.02 Billion INR | -1526.205% |
| Procter & Gamble Health Limited | 11.51 Billion INR | -609.758% |
| FDC Limited | 19.42 Billion INR | -320.556% |
| Krebs Biochemicals & Industries Limited | 504.21 Million INR | -16105.706% |
| Granules India Limited | 45.06 Billion INR | -81.325% |
| Medicamen Biotech Limited | 1.79 Billion INR | -4457.098% |
| Alkem Laboratories Limited | 126.67 Billion INR | 35.495% |
| AstraZeneca Pharma India Limited | 12.95 Billion INR | -530.719% |
| Biofil Chemicals and Pharmaceuticals Limited | 400.35 Million INR | -20309.888% |
| Brooks Laboratories Limited | 794.86 Million INR | -10179.986% |
| Megasoft Limited | 373.95 Million INR | -21750.767% |
| ZIM Laboratories Limited | 3.67 Billion INR | -2123.902% |
| Strides Pharma Science Limited | 40.51 Billion INR | -101.701% |
| Neuland Laboratories Limited | 15.58 Billion INR | -424.269% |
| Morepen Laboratories Limited | 17.01 Billion INR | -380.12% |
| Hikal Limited | 17.84 Billion INR | -357.871% |
| Indoco Remedies Limited | 17.89 Billion INR | -356.63% |
| Aarti Pharmalabs Limited | 18.15 Billion INR | -350.076% |
| Kilitch Drugs (India) Limited | 1.54 Billion INR | -5193.145% |
| Mangalam Drugs & Organics Limited | 3.68 Billion INR | -2116.841% |
| Hester Biosciences Limited | 3.04 Billion INR | -2583.063% |